Racura Oncology Ltd (ASX:RAC)
Australia
· Delayed Price · Currency is AUD
2.340
-0.120 (-4.88%)
At close: Mar 9, 2026
Racura Oncology Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -9.39 | -4.79 | -13.82 | -9.92 | -11.2 | -6.34 | |
| Depreciation & Amortization | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | |
| Stock-Based Compensation | 1.42 | 1.42 | 1.43 | 0.59 | 3.07 | 2.28 | |
| Other Operating Activities | 1.85 | 0.01 | - | 0.08 | 0.04 | -0.01 | |
| Change in Accounts Receivable | 0.08 | 0.08 | 1.6 | -1.64 | 0.07 | -0.08 | |
| Change in Accounts Payable | -0.46 | -0.46 | 0.68 | -0.27 | 0.89 | 0.28 | |
| Change in Other Net Operating Assets | -1.12 | -1.12 | 0.28 | 0.23 | 0.59 | -1.11 | |
| Operating Cash Flow | -7.33 | -4.57 | -9.55 | -10.65 | -6.26 | -4.7 | |
| Investing Cash Flow | 0 | - | - | - | - | - | |
| Issuance of Common Stock | 9.51 | 1.06 | 5.21 | - | 30.98 | 12.79 | |
| Other Financing Activities | - | - | -0 | -1.28 | -0.46 | -0.51 | |
| Financing Cash Flow | 9.51 | 1.06 | 5.21 | -1.28 | 30.51 | 12.28 | |
| Foreign Exchange Rate Adjustments | -0.01 | -0.01 | 0.01 | -0.09 | -0.04 | 0.01 | |
| Net Cash Flow | 2.16 | -3.52 | -4.33 | -12.02 | 24.22 | 7.59 | |
| Cash Income Tax Paid | 2.47 | - | - | - | - | -0.39 | |
| Levered Free Cash Flow | -3.38 | -2.72 | -4.31 | -7.36 | -2.1 | -2.14 | |
| Unlevered Free Cash Flow | -3.38 | -2.72 | -4.31 | -7.36 | -2.1 | -2.14 | |
| Change in Working Capital | -1.5 | -1.5 | 2.56 | -1.68 | 1.55 | -0.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.